Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Clinical trial NCT00004012 · COMPLETED

Trial details

NCT number: NCT00004012
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal Cavity Cancer

Start date: 1998-12-01
Primary completion: 2000-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.